Association of elevated serum soluble CD226 levels with the disease activity and flares of systemic lupus erythematosus
Abstract CD226 is an activating receptor expressed on the cell surface of natural killer cells and T cells. Although CD226 polymorphism is known to be involved in systemic lupus erythematosus (SLE), the involvement of soluble CD226 (sCD226) in SLE is still unknown. In the present study, we measured...
Guardado en:
Autores principales: | , , , , , , , , , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/184c7d5b436a488e8be4ca2c72aa394a |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:184c7d5b436a488e8be4ca2c72aa394a |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:184c7d5b436a488e8be4ca2c72aa394a2021-12-02T15:08:39ZAssociation of elevated serum soluble CD226 levels with the disease activity and flares of systemic lupus erythematosus10.1038/s41598-021-95711-22045-2322https://doaj.org/article/184c7d5b436a488e8be4ca2c72aa394a2021-08-01T00:00:00Zhttps://doi.org/10.1038/s41598-021-95711-2https://doaj.org/toc/2045-2322Abstract CD226 is an activating receptor expressed on the cell surface of natural killer cells and T cells. Although CD226 polymorphism is known to be involved in systemic lupus erythematosus (SLE), the involvement of soluble CD226 (sCD226) in SLE is still unknown. In the present study, we measured serum sCD226 levels using an enzyme-linked immunosorbent assay in 58 SLE patients and 33 healthy controls (HCs) and evaluated their associations with SLE Disease Activity Index 2000 (SLEDAI-2K), clinical manifestations, laboratory data, and the cumulative probability of flare. Serum sCD226 levels showed no significant differences between SLE patients and HCs. However, sCD226 levels were significantly elevated in active SLE patients with a SLEDAI-2K score of ≥ 20 compared with HCs. In SLE patients, sCD226 levels were significantly correlated with SLEDAI-2K scores and anti-dsDNA antibody titers. Moreover, the cumulative probability of flare was markedly higher in patients with high sCD226 than in those with low sCD226. In patients with neuropsychiatric involvement, sCD226 levels were elevated and reflected neuropsychiatric disease activity. These findings indicate that serum sCD226 levels are associated with disease activity and flares of SLE. Thus, it may be a useful biomarker for SLE, and its monitoring allows for more precise SLE management.Miki NakanoMasahiro AyanoKazuo KushimotoShotaro KawanoKazuhiko HigashiokaShoichiro InokuchiHiroki MitomaYasutaka KimotoMitsuteru AkahoshiNobuyuki OnoYojiro ArinobuKoichi AkashiTakahiko HoriuchiHiroaki NiiroNature PortfolioarticleMedicineRScienceQENScientific Reports, Vol 11, Iss 1, Pp 1-8 (2021) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Medicine R Science Q |
spellingShingle |
Medicine R Science Q Miki Nakano Masahiro Ayano Kazuo Kushimoto Shotaro Kawano Kazuhiko Higashioka Shoichiro Inokuchi Hiroki Mitoma Yasutaka Kimoto Mitsuteru Akahoshi Nobuyuki Ono Yojiro Arinobu Koichi Akashi Takahiko Horiuchi Hiroaki Niiro Association of elevated serum soluble CD226 levels with the disease activity and flares of systemic lupus erythematosus |
description |
Abstract CD226 is an activating receptor expressed on the cell surface of natural killer cells and T cells. Although CD226 polymorphism is known to be involved in systemic lupus erythematosus (SLE), the involvement of soluble CD226 (sCD226) in SLE is still unknown. In the present study, we measured serum sCD226 levels using an enzyme-linked immunosorbent assay in 58 SLE patients and 33 healthy controls (HCs) and evaluated their associations with SLE Disease Activity Index 2000 (SLEDAI-2K), clinical manifestations, laboratory data, and the cumulative probability of flare. Serum sCD226 levels showed no significant differences between SLE patients and HCs. However, sCD226 levels were significantly elevated in active SLE patients with a SLEDAI-2K score of ≥ 20 compared with HCs. In SLE patients, sCD226 levels were significantly correlated with SLEDAI-2K scores and anti-dsDNA antibody titers. Moreover, the cumulative probability of flare was markedly higher in patients with high sCD226 than in those with low sCD226. In patients with neuropsychiatric involvement, sCD226 levels were elevated and reflected neuropsychiatric disease activity. These findings indicate that serum sCD226 levels are associated with disease activity and flares of SLE. Thus, it may be a useful biomarker for SLE, and its monitoring allows for more precise SLE management. |
format |
article |
author |
Miki Nakano Masahiro Ayano Kazuo Kushimoto Shotaro Kawano Kazuhiko Higashioka Shoichiro Inokuchi Hiroki Mitoma Yasutaka Kimoto Mitsuteru Akahoshi Nobuyuki Ono Yojiro Arinobu Koichi Akashi Takahiko Horiuchi Hiroaki Niiro |
author_facet |
Miki Nakano Masahiro Ayano Kazuo Kushimoto Shotaro Kawano Kazuhiko Higashioka Shoichiro Inokuchi Hiroki Mitoma Yasutaka Kimoto Mitsuteru Akahoshi Nobuyuki Ono Yojiro Arinobu Koichi Akashi Takahiko Horiuchi Hiroaki Niiro |
author_sort |
Miki Nakano |
title |
Association of elevated serum soluble CD226 levels with the disease activity and flares of systemic lupus erythematosus |
title_short |
Association of elevated serum soluble CD226 levels with the disease activity and flares of systemic lupus erythematosus |
title_full |
Association of elevated serum soluble CD226 levels with the disease activity and flares of systemic lupus erythematosus |
title_fullStr |
Association of elevated serum soluble CD226 levels with the disease activity and flares of systemic lupus erythematosus |
title_full_unstemmed |
Association of elevated serum soluble CD226 levels with the disease activity and flares of systemic lupus erythematosus |
title_sort |
association of elevated serum soluble cd226 levels with the disease activity and flares of systemic lupus erythematosus |
publisher |
Nature Portfolio |
publishDate |
2021 |
url |
https://doaj.org/article/184c7d5b436a488e8be4ca2c72aa394a |
work_keys_str_mv |
AT mikinakano associationofelevatedserumsolublecd226levelswiththediseaseactivityandflaresofsystemiclupuserythematosus AT masahiroayano associationofelevatedserumsolublecd226levelswiththediseaseactivityandflaresofsystemiclupuserythematosus AT kazuokushimoto associationofelevatedserumsolublecd226levelswiththediseaseactivityandflaresofsystemiclupuserythematosus AT shotarokawano associationofelevatedserumsolublecd226levelswiththediseaseactivityandflaresofsystemiclupuserythematosus AT kazuhikohigashioka associationofelevatedserumsolublecd226levelswiththediseaseactivityandflaresofsystemiclupuserythematosus AT shoichiroinokuchi associationofelevatedserumsolublecd226levelswiththediseaseactivityandflaresofsystemiclupuserythematosus AT hirokimitoma associationofelevatedserumsolublecd226levelswiththediseaseactivityandflaresofsystemiclupuserythematosus AT yasutakakimoto associationofelevatedserumsolublecd226levelswiththediseaseactivityandflaresofsystemiclupuserythematosus AT mitsuteruakahoshi associationofelevatedserumsolublecd226levelswiththediseaseactivityandflaresofsystemiclupuserythematosus AT nobuyukiono associationofelevatedserumsolublecd226levelswiththediseaseactivityandflaresofsystemiclupuserythematosus AT yojiroarinobu associationofelevatedserumsolublecd226levelswiththediseaseactivityandflaresofsystemiclupuserythematosus AT koichiakashi associationofelevatedserumsolublecd226levelswiththediseaseactivityandflaresofsystemiclupuserythematosus AT takahikohoriuchi associationofelevatedserumsolublecd226levelswiththediseaseactivityandflaresofsystemiclupuserythematosus AT hiroakiniiro associationofelevatedserumsolublecd226levelswiththediseaseactivityandflaresofsystemiclupuserythematosus |
_version_ |
1718388044768215040 |